Cargando…
Molecular biomarker‐guided anti‐angiogenic targeted therapy for malignant glioma
Despite aggressive multimodality treatment, the prognosis of glioma, especially malignant glioma, remains very poor. After decades of effort, anti‐angiogenic therapy has become an important method of cancer treatment in addition to surgery, radiotherapy and chemotherapy. Although the performance of...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653115/ https://www.ncbi.nlm.nih.gov/pubmed/31210419 http://dx.doi.org/10.1111/jcmm.14417 |